Crystal structure of ( <i>E</i> )-4-(4-(1H-1,2,4-triazol-1-yl)benzylidene)-6,8-dimethoxy-3,4-dihydrobenzo[ <i>b</i> ]oxepin-5( <i>2H</i> )-one, C <sub>21</sub> H <sub>19</sub> N <sub>3</sub> O <sub>4</sub>
Abstract C 21 H 19 N 3 O 4 , triclinic, <m:math xmlns:m="http://www.w3.org/1998/Math/MathML" overflow="scroll"> <m:mrow> <m:mi>P</m:mi> <m:mover accent="true"> <m:mn>1</m:mn> <m:mo>‾</m:mo> </m:mover> </m:mrow> </m:math> $P\overline{1}$ (no. 2), a = 7.1708(3) Å, b = 9.1832(4) Å, c = 14.0711(6) Å, α = 80.297(4)°, β = 88.910(3)°, γ = 69.639(4)°, V = 855.49(7) Å 3 , Z = 2, R gt ( F ) = 0.0372, wR ref ( F 2 ) = 0.0975, T = 100 K.
Authors
- Gui‐Ge Hou (ORCID: https://orcid.org/0000-0002-9493-3981)
- Hui Pan (ORCID: https://orcid.org/0000-0002-6515-4970)
- De-Li Xia
Institutions
- Binzhou Medical University (CN)
- Shandong University of Aeronautics (CN)
- State Intellectual Property Office (CN)
Publication Details
- Journal
- Zeitschrift für Kristallographie - New Crystal Structures
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1515/ncrs-2025-0295
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 0.00